Evoke Pharma Inc. (EVOK)
4.26
0.03 (0.71%)
At close: Jan 14, 2025, 3:58 PM
4.31
1.17%
After-hours Jan 14, 2025, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -7.79M | -8.22M | -8.54M | -13.15M | -7.13M | -7.57M | -12.23M | -10.75M | -12.12M | -13.25M | -2.84M | -2.02M | -2.40M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.13M | 1.46M | 1.88M | 1.63M | 1.37M | 1.54M | 1.82M | 1.71M | 1.50M | 1.10M | 145.97K | 12.51K | 22.70K |
| Other Working Capital | 1.14M | 505.61K | -4.84M | 112.99K | -116.68K | -78.17K | 24.66K | 554.01K | 98.19K | -287.50K | -789.77K | n/a | n/a |
| Other Non-Cash Items | 129.07K | 37.02K | -75.13K | 1.45M | 1.37M | -433.39K | 1.01M | 56.97K | 43.57K | 65.47K | 112.09K | -3.21K | -3.07K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.55M | 132.41K | -5.62M | 4.90M | -10.40K | -518.56K | 687.83K | 277.30K | 77.70K | 579.06K | -461.86K | 258.37K | -511.50K |
| Operating Cash Flow | -4.98M | -6.60M | -12.35M | -6.63M | -5.76M | -6.98M | -8.72M | -8.71M | -10.50M | -11.50M | -3.04M | -1.75M | -2.89M |
| Capital Expenditures | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 5.10M | n/a | n/a | n/a | -4.50M | n/a | 1.50M | 2.00M | 1.00M | -277.78K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -119.30K | -148.99K | -1.27M | 3.93M | n/a | n/a | n/a | n/a | n/a | -82.69K | n/a | n/a | n/a |
| Financial Cash Flow | -119.30K | 7.29M | 13.43M | 9.04M | 6.11M | 4.62M | 7.39M | 9.02M | 5.03M | 1.46M | 27.12M | 1.00M | -277.78K |
| Net Cash Flow | -5.10M | 698.99K | 1.08M | 2.41M | 344.83K | -2.36M | -1.33M | 315.92K | -5.46M | -10.04M | 24.08M | -749.86K | -3.17M |
| Free Cash Flow | -4.98M | -6.60M | -12.35M | -6.63M | -5.76M | -6.98M | -8.72M | -8.71M | -10.50M | -11.50M | -3.04M | -1.75M | -2.89M |